Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl-Philipp Hackstein

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cell Reports|September 19, 2019
TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector FunctionsTianqi Leng, Hossain Delowar Akther, Carl-Philipp Hackstein, et al.
Frontiers in Immunology|September 15, 2023
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family membersCecilia Jay, Emily Adland, Anna Csala, et al.
Nature Communications|December 3, 2022
A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and miceCarl-Philipp Hackstein, Dana Costigan, Linnea Drexhage, et al.
Nature|January 8, 2025
Precursors of exhausted T cells are pre-emptively formed in acute infectionTalyn Chu, Ming Wu, Barbara Hoellbacher, et al.
Journal of Hepatology|March 4, 2023
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injuryCarl-Philipp Hackstein, Jasper Spitzer, Konstantinos Symeonidis, et al.
Clinical and Experimental Immunology|April 20, 2024
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recoveryMohammad Ali, Stephanie Longet, Isabel Neale, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency VirusSarah Fidler, Julie Fox, Timothy Tipoe, et al.
Nature Communications|December 15, 2020
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case reportMatthew S Buckland, James B Galloway, Caoimhe Nic Fhogartaigh, et al.
Nature Communications|April 7, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responsesAne Ogbe, Barbara Kronsteiner, Donal T Skelly, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cell Reports|September 19, 2019
TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector FunctionsTianqi Leng, Hossain Delowar Akther, Carl-Philipp Hackstein, et al.
Frontiers in Immunology|September 15, 2023
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family membersCecilia Jay, Emily Adland, Anna Csala, et al.
Nature Communications|December 3, 2022
A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and miceCarl-Philipp Hackstein, Dana Costigan, Linnea Drexhage, et al.
Nature|January 8, 2025
Precursors of exhausted T cells are pre-emptively formed in acute infectionTalyn Chu, Ming Wu, Barbara Hoellbacher, et al.
Journal of Hepatology|March 4, 2023
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injuryCarl-Philipp Hackstein, Jasper Spitzer, Konstantinos Symeonidis, et al.
Clinical and Experimental Immunology|April 20, 2024
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recoveryMohammad Ali, Stephanie Longet, Isabel Neale, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency VirusSarah Fidler, Julie Fox, Timothy Tipoe, et al.
Nature Communications|December 15, 2020
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case reportMatthew S Buckland, James B Galloway, Caoimhe Nic Fhogartaigh, et al.
Nature Communications|April 7, 2021
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responsesAne Ogbe, Barbara Kronsteiner, Donal T Skelly, et al.
Pageof 3